RT Journal Article
SR Electronic
T1 Forecasting COVID-19: Using SEIR-D quantitative modelling for healthcare demand and capacity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.29.20164566
DO 10.1101/2020.07.29.20164566
A1 Campillo-Funollet, Eduard
A1 Van Yperen, James
A1 Allman, Phil
A1 Bell, Michael
A1 Beresford, Warren
A1 Clay, Jacqueline
A1 Evans, Graham
A1 Dorey, Matthew
A1 Gilchrist, Kate
A1 Gurprit, Pannu
A1 Walkley, Ryan
A1 Watson, Mark
A1 Madzvamuse, Anotida
YR 2020
UL http://medrxiv.org/content/early/2020/08/01/2020.07.29.20164566.abstract
AB Rapid evidence-based decision-making and public policy based on quantitative modelling and forecasting by local and regional National Health Service (NHS-UK) managers and planners in response to the deadly severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), a virus causing COVID-19, has largely been missing. In this pilot study, we present a data-driven epi-demiological modelling framework that allows to integrate quantitative modelling, validation and forecasting based on current available local and regional datasets to investigate and mitigate the impact of COVID-19 on local NHS hospitals in terms of healthcare demand and capacity as well as allowing for a systematic evaluation of the predictive accuracy of the modelling framework for long-term forecasting. We present an epidemiological model tailored and designed to meet the needs of the local health authorities, formulated to be fitted naturally to datasets which incorporate regional and local demographics. The model yields quantitative information on the healthcare demand and capacity required to manage and mitigate the COVID pandemic at the regional level. Furthermore, the model is rigorously validated using partial historical datasets, which is then used to demonstrate the forecasting power of the model and also to quantify the risk associated with the decision taken by healthcare managers and planners. Model parameters are fully justified, these are derived purely based on the time series data available at the regional level, with minimal assumptions. Using these inferred parameters, the model is able to make predictions under which secondary waves and re-infection scenarios could occur. Hence, our modelling approach addresses one of the major criticisms associated with the lack of transparency and precision of current COVID-19 models. Our approach offers a robust quantitative modelling framework where the probability of the model giving a wrong or correct prediction can be quantified.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAll the authors are funded from their respective institutions. None of the authours received third party payments for any aspect of the submitted work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:None required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in the manuscript is available from public sources.